ADIPOQ and Hepatic steatosis: In these conditions, the drastic plasma reduction of leptin and adiponectin associated with CLA treatment, induces fatty liver and hyperinsulinaemia, not through the direct induction of hepatic lipid synthesis and insulin resistance, but because of the scarcity of the adipose tissue [30].